| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0019 | 0.9 |